Erlotinib

Cat. No.: PI183321746

Description: Erlotinib is a selective inhibitor of tyrosine kinase that prevents signal transmission of important growth factors. This stops tumor growth. Erlotinib was approved in the EU in 2005 and in 2007 the indication of non-small cell bronchial carcinoma was extended to include the treatment of pancreatic cancer.